|
Volumn 346, Issue , 2013, Pages
|
EMA consults public on plan to increase transparency of drug trial data.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLINICAL TRIAL (TOPIC);
COMMERCIAL PHENOMENA;
DECISION MAKING;
DRUG CONTROL;
DRUG INDUSTRY;
EUROPE;
FEMALE;
GOVERNMENT;
HUMAN;
MALE;
MEDICAL INFORMATION;
POLICY;
STANDARDS;
TRENDS;
CLINICAL TRIALS AS TOPIC;
COMMERCE;
DECISION MAKING;
DRUG AND NARCOTIC CONTROL;
DRUG INDUSTRY;
EUROPE;
FEMALE;
GOVERNMENT AGENCIES;
HEALTH COMMUNICATION;
HUMANS;
MALE;
ORGANIZATIONAL POLICY;
PUBLIC POLICY;
|
EID: 84891720050
PISSN: None
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.f4124 Document Type: Note |
Times cited : (2)
|
References (0)
|